Atlas Trials

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

Clinical trial NCT03381092 · UNKNOWN

Trial details

NCT number
NCT03381092
Sponsor
Peking University
Status
UNKNOWN
Study type
OBSERVATIONAL
Invasive Breast Cancer
Start date
2017-12-22
Primary completion
2022-06-30
Enrollment
348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.